Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells by unknown
Molecular Cloning of CD44R1 and CD44R2, Two
Novel Isoforms of the Human CD44 Lymphocyte
"Homing" Receptor Expressed by Hemopoietic Cells
By Graeme J. Dougherty,* Peter M. Lansdorp,"$ David L. Cooper,§
and R. Keith Humphries"$
From the "Terry Fox Laboratory for Hematology/Oncology, British Columbia Cancer Research
Centre, Vancouver, British Columbia, V5Z 1L3, Canada; the #Department of Medicine,
University of British Columbia, Vancouver, British Columbia, V6T IW5, Canada; and the
§Department ofPathology, Duke University Medical Center, Durham, North Carolina 27710
Summary
In addition to the 85-95 kD CD44 species found on most hemopoietic cell types, the human
myelomonocytic cell line KG1a expresses proteins of approximately 115 kD and 130 kD that
react with monoclonal antibodies belonging to CD44. The possibility that these higher molecular
weight species may represent novel CD44 isoforms containing additional protein sequence was
investigated. CD44 cDNA clones were isolated from a plasmid-based expression library prepared
from KG1a mRNA. One of the three clones obtained (clone 2.3) was found to encode a CD44
molecule of approximately 130 kD in transfected COS cells. Sequence analysis indicated that
the molecule encoded by this cDNA clone, designated CD44R1, was essentially identical to
CD44 except for the presence of an additional 132 amino acids inserted into the extracellular
domain. This inserted region is rich in serine and threonine residues that may serve as sites of
0-linked glycosylation, and contains a potential site of Winked glycosylation and a potential
site ofchondroitin sulphate attachment. PCR analysis using primers that flank the inserted region
present within CD44R1 identified an additional CD44 isoform, designated CD44R2, that contains
only the last 69 amino acids present within the unique region of CD44R1. Peripheral blood
mononuclear cells and granulocytes from normal individuals and patients with chronic myelogenous
leukemia, polycythemia vera, or acute myelomonocytic leukemia, express both CD44R1 and
CD44R2. In contrast, CD44R1 and CD44R2 appear to be differentially expressed in various
CD44-positive cell lines. Thus KG1a, and the Epstein-Barr Virus-transformed B cell lines WalkDR4
and Way-1 express both CD44 and the CD44 isoforms CD44R1 and CD44R2, while the myeloid
cell lines HL60 and U937 express high levels of CD44, but only very low levels of CD44R1
and CD44R2. The CD44-negative cell lines DHL4, DHIA0, Jurkat, and K562 are also negative
for CD44R1 and CD44R2.
T
he entry of PBLs into lymphoid tissues and sites of inflam-
mation depends upon initial adhesion to vascular en-
dothelium. Various proteins expressed on the surface of leu-
kocytes have been implicated in this interaction including
CD44, LFA1(CD11a/CD18), Mac-1 (CD11b/CD18), LeuM8/
LAM-1, and the fibronectin receptor VLA-4 (ot4i, CD49d/
CD29) (1-4). Particular attention has focused on CD44 since
antibodies directed against distinct epitopes on this molecule
selectively block the binding of lymphocytes to endothelial
cells in some lymphoid tissues but not others (5, 6). The
mechanism by which CD44 mediates such tissue-specific
"homing" remains to be determined. There are, however, sev-
eral possibilities. First, there may be a single CD44 protein
with the specificity of binding determined by cell-specific
differences in the degree and/or type of glycosylation. Alter-
natively, there may be multiple CD44 proteins each sharing
extensive sequence homology but differing from one another
in cellular distribution and binding specificity. Until now,
available evidence has supported only the first of these possi-
bilities. For example, the alternative forms of CD44 expressed
by certain cell types have been shown, in several studies, to
be produced as a result of the differential modification of a
common polypeptide core (7, 8). Similarly, the sequencing
of CD44 cDNAs isolated from different lymphoid cell
lines has revealed only one major species (9, 10). Moreover,
Northern blot analysis, has demonstrated that CD44 mRNA
transcripts of identical size are present in a variety of hemo-
poietic cell types (9, 10). Such findings have lead to the sug-
gestion that the tissue-specificity of lymphocyte-endothelial
cell interactions is not mediated by CD44 alone, but is the
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other differentially expressed adhesion molecules (1, 3, 10,
11) (Dougherty, G.J., P. Lansdorp, C. Smith, and R.K. Hum-
phries, manuscript submitted for publication).
In the present study, we describe the molecular cloning
of two novel CD44 isoforms, designated CD44R1 and
CD44R2. CD44R1, differs from CD44, in that it contains
an additional 132 amino acids inserted into the extracellular
domain close to the membrane spanning domain. CD44R2
contains a similarly positioned insert that corresponds to the
last 69 amino acids present within the unique region of
CD44RL Sequence analysis indicates that trypsin-like pro-
teases couldperhaps cleave within the inserted regions present
within CD44R1 and CD44R2, generating soluble forms of
CD44 that could play a role in regulating CD44-mediated
adhesive interactions. Alternatively, these inserted regions may
instead contribute to CD44 heterogeneity and the resultant
tissue specificity of CD44-mediated leukocyte "homing".
Materials and Methods
Cell Lines and Primary Cell Populations.
￿
The myelomonocytic
cell line KGl and its derivative KGla, the promyelocytic cell line
HL60, the histiocytic cell line U937, the T cell leukemia lineJurkat,
and the chronic myelogenous leukemia cell line K562 were all ob-
tained from the American Type Culture Collection, (Rockville,
MD). The B cell lymphoma lines DHL4 and DHIT10, and the
EBVtransformed B cell lines WalkDR4 and Way-1 were obtained
from colleaguesin the Terry Fox Laboratory. PBMCs were isolated
from normal individuals and those with chronic myelogenous
leukemia, polycythemia vera, and acute myelomonocytic leukemia
by centrifugation through Ficoll-Hypaque. PMN cells were purified




The production and character-
ization of the CD44 mAbs 7f4, 8d8 and la5 has been described
in detail elsewhere (Dougherty, G.J., P. Lansdorp, C. Smith, and
R.K. Humphries, manuscript submitted for publication). mAbs
F10-44-2 (CD44), G19-1 (CD43) and 8F5 (CD54) were obtained
from the Myeloid panel of the Fourth International Conference
and Workshop on HumanLeukocyte Differentiation antigens (13).
mAb 50B4 (CD44) (14) was a generous gift from Dr. Michelle




pCDw44, a full length human CD44 cDNA
clone in expression vector CDM8 (9), was a generous gift from
Dr. Brian Seed (Massachusetts General Hospital, Boston, MA).
Construction ofthe KGla cDNA Library.
￿
A plasmid-based cDNA
library of approximately 2 x 106 recombinants with a mean in-
sert size of 2 kb was prepared from Poly A' mRNA isolated from
KGla cells using the expression vector CDM8 as previously de-
scribed (15).
IsolationofcDNA Clones Encoding CD44RL
￿
Bacterial colonies
comprising the primary cDNA library were pooled and used to
transfect approximately 106 COS7 cells by protoplast fusion. After
a 72-h incubation period to allow replication of the transfected
plasmids and expressionoftheircDNA inserts, cells expressingsur-
face proteins reactive with mAbs 7f4, 8d8, and la5 were isolated
by panning (16). Plasmids were recovered from these cells by Hirt
extraction, transformed back into bacteria and subjected to a fur-
ther round of protoplast fusion and selection . Plasmids recovered
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from cells isolated in the second round of selection were again trans-
formed into bacteria and individual colonies picked. COS7 cells
transfected with plasmid DNA isolated from 4 of 10 clones exam-
ined reacted with the CD44 mAbs 74, Sd8, 1a5, F10-44-2, and
50B4 but not with control mAbs belonging to CD43 (G19-1) and
CD54 (8F5). None of these antibodies reacted with COS7 cells
transfected with the CDM8 vector alone.
DNASequencing.
￿
Restriction fragments ofcDNA inserts were
subdoned into pUC 19 and sequenced by the dideoxy chain termi-
nation method, using denatured double stranded templates and T7
DNA polymerase (17), with reaction conditions as suggested by
the manufacturer (Pharmacia Fine Chemicals).
Western Blot Analysis.
￿
Western blot analysis of CD44 expres-
sion in transfected COS cells and primary cell lines was carried
out as previously described (18) except that peroxidase-conjugated
rabbit anti-mouse IgG (DakoCorporation, Carpinteria, CA) was
used as a second antibody.
Polymerase Chain Reaction (PCR) Analysis.
￿
PCR analysis was
used to identify CD44R2 and to determine the expression ofboth
CD44R1 and CD44R2 in various cell lines and primary cell popu-
lations. Briefly, totalcellular RNA was isolated from the cell types
indicated using the guanidinium isothiocyanate procedure (19) .
cDNA was synthesized from 51Ag oftotalcellular RNA byreverse
transcription using Moloney leukemia virus-reverse transcriptase
and oligo-dT primers, and PCR reactions carried out exactly as
described in the Clonetech Laboratories Inc. Cytokine Mapping
process (Clonetech Laboratories Ltd., Palo Alto, CA). The oligo-
nucleotide primers used were 23mers 5'-000ACAGCACAGAC-
AGAATCCCT-3'and 5'-ATCTGATTCAGATCCATGAGTGG-3'.
5 Al aliquots of the PCR reaction were separated on a 2% agarose
gel, transferred to nylon membranes and probed as described (20-22).
Results and Discussion
The predominant CD44 species expressed by lymphocytes
and other hemopoietic cell types has a mol wt of approxi-
mately 85-95 kD (1-7, 9, 10) . In the myelomonocytic cell
line KGla however, additional species of approximately 115
kD and 130 kD are also evident (Fig. 1). We considered the
possiblity that these additional species may represent novel
isoforms of CD44 containing additional peptide sequence.
To investigate this possibility, CD44 cDNAs were cloned from
a plasmid-based expression library prepared from KGla
mRNA. The CD44 cDNAs obtained were transfected into
COS7 cells and the proteins produced examined by Western
blot.
As shown in Fig. 1, two of the three cDNAs isolated (clones
2.2 and 2.7) encoded CD44 molecules of approximately 85
kD. Although somewhat smaller and more heterogeneous
than the form of CD44 expressed by KGla cells, these mole-
cules are nevertheless similar in size to the CD44 protein pro-
ducedin COS7 cells transfected with the humanCD44 cDNA
clone pCDw44 (9). In contrast, the third clone isolated, desig-
nated 2.3, encoded a molecule ofapproximately 130 kD similar
in size to the larger of the two unusual CD44 species ex-
pressed in KGla.
Clone 2.3 was sequenced and shown to encode a molecule
that differed from previously described CD44 cDNAs (9, 10)
by the presence of an additional 132 amino acids inserted into
the extracellular domain proximal to the transmembrane re-Figure 1 .
￿
Western blot analysis of CD44 expression in KGla cells, and
COS cells transfected with human CD44 cDNAs. COS cells were trans-
fected with plasmid DNA by electroporation. 72 h later, cells were har-
vested with PBS containing 2 mM EDTA . Whole cell detergent lysates
were separated on a 5% SDS-PAGE gel, transferred to nitrocellulose and
CD44 proteins identified by staining with mAbs 8d8 or 50B4, followed
by a peroxidase-conjugated rabbit anti-mouse IgG second antibody. The
reaction was developed by incubating the blots in PBS containing 0.06%
(w/v) diaminobenzidine and 0.012% (v/v) H202 .
gion (Fig. 2) . This inserted region is rich in serine and threo-
nine residues which could potentially serve as sites of O-linked
glycosylation . It also contains an additional N-linked glycosy-
lation site and an additional serine-glycine dipeptide that may
serve as a site of attachment for chondroitin sulphate (23) .
Interestingly, this region also contains an arginine dipeptide,
a motif that has been shown in other cell surface proteins
to serve as a site of posttranslational cleavage by trypsin-like
proteases (24-26) . Cleavage at this site would produce a soluble
form ofCD44 . A soluble protein related to CD44 has been
identified in the serum (27) . Although the function of this
molecule is not known, it has been suggested to play a role
in regulating CD44-mediated cellular interactions (2) . We
have designated this novel form of CD44, CD44R1 .
RNA isolated from various primary cell populations and
cell lines was analyzed for the expression ofCD44 transcripts
by PCR using primers that flank the unique region present
within CD44R1. Ethidium bromide staining of the PCR
products produced, gave a major band of approximately 90
by in the CD44-positive cell lines KG1a, HL60, U937,
WalkDR4, Way-1, and in PBMC and granulocyte prepara-
tions (data not shown) . This species was not present in the
CD44-negative cell linesDHL4,DHL10, Jurkat, and K562,
and corresponds to the expected size of material produced
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Figure 2 .
￿
Nucleotide and deduced amino acid sequence of the inserted
regions present in CD44R1 and CD44R2 . CD44 and CD44R1 are drawn
to scale. Shaded areas indicate the putative hydrophobic leader and
membrane-spanning domains. A potential N-linked glycosylation site (Asn-
X-Ser/Thr) is underlined . A potential chondroitin sulphate attachment
site (Ser-Gly) is boxed. The arginine dipeptide that may serve as a site
of cleavage by trypsin-like proteases is arrowed .
as a result of the amplification of CD44 (9, 10) . Several less
highly expressed products were also evident in material
amplified from some of the CD44-positive cell populations .
As shown in Fig . 3, two of these species (487 by and 395
bp) were found to hybridize with a probe spanning the
CD44R1 insert . These PCR products were subcloned into
pUC-based vectors and sequenced. The sequence ofthe larger
of the two PCR products was found to correspond exactly
to CD44R1 . The smallerPCR product in contrast, contained
an identically positioned insert that encoded only the most
COOH-terminal 69 amino acids present within the inserted
region of CD44R1 (Fig . 2) . We have designated this latter
CD44 isoform CD44R2 . The inserted region of CD44R1
appears to be encoded by three exons present within a single
CD44 gene located on the short arm of chromosome 11 (data
not shown) . Only the third of these three exons is present
in CD44R2 . Presumably, CD44, CD44R1 andCD44R2 are
generated by alternative slicing of the CD44 gene.
Asshown in Fig. 3, PBMC and granulocytes (PMN) from
normal individuals and patients with chronic myelogenous
leukemia, polycythemia vera, or acute myelomonocytic leu-
kemia express both CD44R1 and CD44R2. In contrast,
CD44R1 and CD44R2 appear to be differentially expressed
in various CD44-positive cell lines . Thus KG1a, and the EBV
transformed B cell lines WalkDR4 and Way-1 express both
CD44 (Dougherty, G .J ., P. Lansdorp, C . Smith, and R.K .
Humphries, manuscript submitted for publication) and the
CD44 isoforms CD44R1 and CD44R2, while the myeloid
cell linesHL60 andU937 express high levels ofCD44 (Dough-
erty, G.J.,P . Lansdorp, C. Smith, andR.K. Humphries, manu-
script submitted for publication), but only very low levels
of CD44R1 and CD44R2 . The CD44-negative cell lines
DHL4, DHL10, Jurkat and K562 are also negative for
CD44R1 and CD44R2 .Figure 3 .
￿
PCR analysis of CD44R1 and CD44R2 expression in various cell lines and primary cell populations. PCR was performed on cDNA
prepared from the indicated cell lines using primers that flank the inserted region present within CD44R1 . Amplified material was separated on a
2% agarose gel, transferred to nylonand hybridized with a probe that encompassed the unique region present in CD44R1 (Hinfl 788 - Hinfl 1145).
PBMNC, peripheral blood mononuclear cells; PMN, polymorphonuclear cells; CML, chronic myelogenous leukemia; PV, polycythemia vera ; AML,
acute myelomonocytic leukemia .
Recently it has been demonstrated that CD44 mediates
the attachment of lymphocytes to endothelium viarecogni-
tion of hyaluronate (28, 29) . The amino terminal region of
CD44 is composed of two domains with extensive sequence
homology to cartilage link proteins (9, 10) which function
to stabilize large aggregates ofcartilage proteoglycans via rec-
ognition of hyaluronate (30) . Interestingly, mAb Hermes 3,
which inhibits the binding of lymphocytes to mucosal en-
dothelium but not synovial or peripheral lymph node en-
dothelium (5, 6), recognizes an epitope onCD44 that is dis-
tinctfrom the putative hyaluronate-binding domain (10) . This
finding raises the possibility that otherregions ofCD44 may
contribute to the specificity of hyaluronate binding perhaps
through therecognition ofother cell surfacemolecules (10) .
Although the functional importance of the inserted region
present in CD44R remains to be determined, it is tempting
to speculate that this domain may somehow contribute to
the tissue specificity of CD44 mediated "homing".
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